{
    "2018-08-16": [
        [
            {
                "time": "2018-08-01",
                "original_text": "Here’s What Tesaro’s Valuation Trend Indicates",
                "features": {
                    "keywords": [
                        "Tesaro",
                        "valuation trend",
                        "indicates"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-01",
                "original_text": "Analysts’ Expectations for Tesaro and Its Peers in August",
                "features": {
                    "keywords": [
                        "analysts",
                        "expectations",
                        "Tesaro",
                        "peers",
                        "August"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-08-01",
                "original_text": "Gauging Analysts’ Expectations for Novavax and Peers in August",
                "features": {
                    "keywords": [
                        "gauging",
                        "analysts",
                        "expectations",
                        "Novavax",
                        "peers",
                        "August"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-08-01",
                "original_text": "The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of COOL, TAL, FPI, ABBV and GDS",
                "features": {
                    "keywords": [
                        "Klein Law Firm",
                        "class actions",
                        "shareholders",
                        "COOL",
                        "TAL",
                        "FPI",
                        "ABBV",
                        "GDS"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "various"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-08-01",
                "original_text": "A Look at the Performance of Bausch Health’s Ortho Dermatologics",
                "features": {
                    "keywords": [
                        "performance",
                        "Bausch Health",
                        "Ortho Dermatologics"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-08-01",
                "original_text": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AbbVie Inc. - ABBV",
                "features": {
                    "keywords": [
                        "SHAREHOLDER ALERT",
                        "Pomerantz Law Firm",
                        "investigates",
                        "claims",
                        "AbbVie Inc.",
                        "ABBV"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}